Browsing Tag
BNT162b2
9 posts
Pfizer withdraws emergency use application for COVID-19 vaccine in India
US pharmaceutical giant Pfizer has withdrawn its application for emergency use authorization of its BNT162b2 COVID-19 vaccine in…
Switzerland becomes first country to grant full approval to Pfizer-BioNTech Covid-19 vaccine
Switzerland becomes the first nation to fully approve the Pfizer-BioNTech Covid-19 vaccine. Find out how Swissmedic's rigorous process could influence global vaccine confidence.
Pfizer and BioNTech’s COVID-19 vaccine secures FDA emergency use authorization
In a groundbreaking move, Pfizer and BioNTech have received emergency use authorization (EUA) from the US Food and…
Pfizer and BioNTech secure Health Canada approval for BNT162b2 Covid-19 vaccine
Pfizer, a leading global pharmaceutical company, and BioNTech, a prominent German biotech firm, have officially secured Health Canada’s…
UK grants emergency authorization for Pfizer and BioNTech’s BNT162b2 Covid-19 vaccine
The UK Medicines and Healthcare Products Regulatory Agency (MHRA) has granted emergency use authorization (EUA) for the BNT162b2…
Pfizer and BioNTech’s Covid-19 vaccine candidate shows over 90% effectiveness in Phase 3 Trial
Pfizer and BioNTech have announced a groundbreaking update in their efforts to combat the Covid-19 pandemic. Their BNT162b2…
Pfizer, BioNTech sign deal to supply BNT162 Covid-19 vaccine to Canada
Pfizer and BioNTech have signed an agreement with the Canadian government to supply their mRNA-based BNT162 vaccine candidate…
BNT162 COVID-19 vaccine candidate : US govt signs $2bn supply deal with Pfizer and BioNTech
Pfizer and BioNTech have bagged a $1.95 billion deal with the US government for supplying 100 million doses…
BNT162b1 and BNT162b2 Covid-19 vaccine candidates get FDA fast track status
Pfizer and BioNTech said that BNT162b1 and BNT162b2, two vaccine candidates developed to give protection against the SARS-CoV-2…